Two studies examining imaging utilization made our top story list this week, one that painted a familiar picture of imaging’s growth and retraction, while the other offered an important reminder about the factors behind imaging use.

IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces today that it has received combined clearances from the U.S. Food and Drug Administration (FDA) that will enable IBA to market-launch the Proton Therapy specific Cone Beam Computed Tomography (CBCT) solution.

The University of California San Francisco is creating a magical new world of woodland forests and cable cars in a family friendly molecular imaging and radiology suite, reports SF Gate. 

The NCAA, the governing body for college sports, has agreed to settle a class-action lawsuit brought by athletes regarding brain trauma received during the course of play, according to an Associated Press report.

Digital breast tomosynthesis has been shown to provide better visualization of architectural distortion, a subtle mammographic finding, and also identifies some distortions that would not be found at all if screening was performed using digital mammography alone, according to a study published in the July issue of American Journal of Roentgenology.

A recent study has shown that providing a formal report for outside images does more than simply offer a second opinion, it leads to a significantly lower chance of repeat imaging.

Bruker Corporation of Billerica, Mass., has announced that the provider of instrumentation for biomedical research has acquired Vutara Incorporated, producers of high-speed and resolution 3D fluorescence microscopy.

Lasting memories of trauma and aversion can be passed on from mother-to-baby in a kind of biochemical generational stamp, researchers from the University of Michigan announced yesterday.